Sponsors (9)
The bill strengthens accountability, transparency, and punitive tools against alleged forced organ harvesting—supporting victims and ethical standards—while trading off some scientific collaboration and flexibility (and imposing compliance, reputational, and diplomatic risks), and limiting import-sanction options as a policy tool.
People harmed by organ trafficking (and advocates) and the U.S. government: creates enforceable tools (visa bans, asset blocks, sanctions coordination) that increase accountability for individuals and entities engaged in alleged involuntary organ harvesting.
U.S. policymakers and taxpayers: requires evidence-gathering and international coordination (reports, allied diplomacy) so policymakers have a detailed, evidence-based picture to inform sanctions, diplomacy, and human-rights responses.
Patients, clinicians, and U.S. medical institutions: limits and discourages U.S. participation in transplant collaborations that could make American institutions complicit in unethical organ harvesting, reinforcing ethical and public-health standards.
Patients, U.S. clinicians, and biomedical researchers: restrictions and limits on collaboration with PRC transplant work, plus public identification of past links, may slow legitimate medical research, reduce training opportunities, limit patient care options, and harm researchers' reputations.
U.S. businesses, banks, and taxpayers: broad sanction authorities, criminal penalties for violations, and compliance requirements could chill lawful commercial transactions, raise compliance costs, and trigger retaliatory measures that increase costs for businesses and consumers.
Immigrants and listed individuals/entities: erroneous or wrongful listing can cause immediate visa revocation, asset freezes, and severe travel/financial disruption without quick remedial processes.
Based on analysis of 6 sections of legislative text.
Requires public lists, sanctions, visa bans, and a U.S. government report to deter and punish involuntary organ harvesting in China and restrict U.S.–China transplant cooperation.
Official title: Provide for the imposition of sanctions with respect to forced organ harvesting within the People's Republic of China, and for other purposes.
Introduced March 3, 2025 by Rafael Edward Cruz · Last progress March 3, 2025
Directs U.S. policy to refuse cooperation with the People’s Republic of China on organ transplantation related activities while the Chinese Communist Party remains in power, and to use sanctions, visa restrictions, and allied coordination to pressure the PRC to end state-sponsored involuntary organ harvesting. It requires the President to produce and maintain a public list of foreign persons responsible for or facilitating involuntary organ harvesting in China and to impose blocking sanctions and visa bans on those listed, with limited humanitarian and intelligence exceptions and a five-year sanctions authority sunset. The State Department must also produce a public report (with optional classified annex) assessing China’s transplant practices, donor numbers, U.S.–China transplant collaborations, and whether persecution of Falun Gong amounts to an atrocity under existing U.S. law.